Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
According to recent announcements, Lexaria has initiated a new preclinical research program designed to evaluate its DehydraTECH platform with emerging GLP 1 candidates including amycretin and retatrutide
In an accompanying editorial, two medical experts at the University of Pittsburgh, Elizabeth Oczypok and Timothy Anderson, suggest that this new class of drugs should be rebranded from weight loss drugs to weight management drugs, which people may need to take indefinitely
Nutrients 12, 1096
Access is narrowing
:
US$ 22.90
US$ 27.60
US$ 27.95
US$ 27.32
